Showing results (81-90 of 163) with videos related to

Sort By:
Pageof 17
Chest|April 1, 1990
A new short infusion dosage regimen of recombinant tissue plasminogen activator in patients with venous thromboembolic diseaseM N Levine, J Weitz, A G Turpie, et al.
Chest|February 7, 2001
Antithrombotic therapy in patients with mechanical and biological prosthetic heart valvesP D Stein, J S Alpert, H I Bussey, et al.
Chest|December 1, 1990
A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolismM Levine, J Hirsh, J Weitz, et al.
Chest|October 1, 1995
Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass graftsP D Stein, J E Dalen, S Goldman, et al.
Thrombosis Research|January 15, 1983
The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effectsM R Buchanan, J A Rischke, R Butt, et al.
Circulation|February 1, 1975
Platelet survival time following aortic valve replacementP Steele, H Weily, H Davies, et al.
Circulation|April 1, 1977
Platelet survival time in patients with hypoxemia and pulmonary hypertensionP Steele, J H Ellis, H S Weily, et al.
The American Journal of Cardiology|September 29, 2000
Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarctionM Cohen, E M Antman, E Gurfinkel, et al.
The Journal of Laboratory and Clinical Medicine|April 1, 1984
Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopeniaJ G Kelton, D Sheridan, H Brain, et al.
The New England Journal of Medicine|August 19, 1993
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacementA G Turpie, M Gent, A Laupacis, et al.
Pageof 17